arrow
H

Hadiza Saidu

universite paris cite
H指数:15
被引数:1,661

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Aspirin Prophylaxis for Preeclampsia Prevention in Nigeria

阿司匹林预防性用于尼日利亚子痫前期预防

JACC
IF0
2025-12-010
PRE
Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF study
2025-02-120
OA
Rapid Uptitration of Guideline-Directed Medical Therapies in Acute Heart Failure With and Without Atrial Fibrillation

伴有与不伴有房颤的急性心力衰竭中指南指导的药物治疗方案的快速滴定

2024-11-011
PRE
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study

从stronte-hf研究中了解贫血的患病率和发生率以及口服心力衰竭治疗的快速滴定

2024-09-111
PRE
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk

急性心力衰竭后药物的滴定治疗在不同风险人群中均安全、耐受性良好且有效。

2024-09-011
PRE
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF

具有生物活性的肾上腺髓质素可作为急性心力衰竭住院患者残余充血和早期再住院的标志物: 来自强HF的数据

2024-06-144
OA
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial

指南指导的药物治疗快速剂量递增对生活质量的影响:来自STRONG-HF试验的启示

2024-04-015
PRE
Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial

因急性心力衰竭入院后接受高强度护理的患者的安全性指标: STRONG-HF试验

2024-04-0110
OA
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial

急性心力衰竭住院后的血压和强化治疗升高: 来自STRONG-HF试验的见解

2024-03-054
PRE
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission

急性心力衰竭入院后循证心力衰竭药物的优化

2024-02-0112
OAAI
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure

急性心力衰竭住院后,在指南指导的药物治疗快速滴定过程中肾功能的早期变化

2023-11-209
OA
Non-cardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG-HF trial
2023-10-0418
OA
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trial

老年患者急性心力衰竭指南指导药物治疗的安全性,耐受性和有效性: 强HF随机临床试验的子分析

2023-06-0722
OA
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trial
2023-06-0120
OA
NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial

Nt-probnp和高强度治疗急性心力衰竭: STRONG-HF试验

2023-05-2234
OA
Safety, tolerability, and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

针对急性心力衰竭 (stronte-hf) 的指南指导药物治疗的安全性,耐受性和有效性: 一项跨国,开放标签,随机试验

LANCET
IF88.5
2022-12-01403
OAAI
Amended STRONG-HF study design
2021-10-0412
OA
Disparities in clinical features and outcomes of peripartum cardiomyopathy in high versus low prevalent regions in Nigeria
2021-06-176
OAAI